These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1742726)

  • 1. Differential expression of bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin.
    Reed JC; Meister L; Tanaka S; Cuddy M; Yum S; Geyer C; Pleasure D
    Cancer Res; 1991 Dec; 51(24):6529-38. PubMed ID: 1742726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
    Krajewski S; Chatten J; Hanada M; Reed JC
    Lab Invest; 1995 Jan; 72(1):42-54. PubMed ID: 7837790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.
    Hanada M; Krajewski S; Tanaka S; Cazals-Hatem D; Spengler BA; Ross RA; Biedler JL; Reed JC
    Cancer Res; 1993 Oct; 53(20):4978-86. PubMed ID: 8402688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the smg p25A (a ras p21-like GTP-binding protein) gene in human neuroblastoma cell lines and tumor tissues.
    Sano K; Nakamura H; Mabuchi S; Tanaka T; Nakagawara A; Takai Y
    Cancer Res; 1990 Nov; 50(22):7242-5. PubMed ID: 2121331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroblastoma: inverse relationship between expression of N-myc and NGF-r.
    Christiansen H; Christiansen NM; Wagner F; Altmannsberger M; Lampert F
    Oncogene; 1990 Mar; 5(3):437-40. PubMed ID: 2156211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of multiple proto-oncogenes is differentially regulated during retinoic acid induced maturation of human neuroblastoma cell lines.
    Thiele CJ; Deutsch LA; Israel MA
    Oncogene; 1988 Sep; 3(3):281-8. PubMed ID: 3060792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phorbol ester-mediated inhibition of growth and regulation of proto-oncogene expression in the human T cell leukemia line JURKAT.
    Makover D; Cuddy M; Yum S; Bradley K; Alpers J; Sukhatme V; Reed JC
    Oncogene; 1991 Mar; 6(3):455-60. PubMed ID: 2011401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple defects of the nerve growth factor receptor in human neuroblastomas.
    Azar CG; Scavarda NJ; Reynolds CP; Brodeur GM
    Cell Growth Differ; 1990 Sep; 1(9):421-8. PubMed ID: 1963076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCL2 and JUNB abnormalities in primary cutaneous lymphomas.
    Mao X; Orchard G; Lillington DM; Child FJ; Vonderheid EC; Nowell PC; Bagot M; Bensussan A; Russell-Jones R; Young BD; Whittaker SJ
    Br J Dermatol; 2004 Sep; 151(3):546-56. PubMed ID: 15377339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
    Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
    Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor 2 induces differentiation and apoptosis of Askin tumour cells.
    Kim MS; Kim CJ; Jung HS; Seo MR; Juhnn YS; Shin HY; Ahn HS; Thiele CJ; Chi JG
    J Pathol; 2004 Jan; 202(1):103-12. PubMed ID: 14694527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides.
    Reed JC; Stein C; Subasinghe C; Haldar S; Croce CM; Yum S; Cohen J
    Cancer Res; 1990 Oct; 50(20):6565-70. PubMed ID: 2208117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle analysis of p26-BCL-2 protein levels in proliferating lymphoma and leukemia cell lines.
    Reed JC; Tanaka S; Cuddy M
    Cancer Res; 1992 May; 52(10):2802-5. PubMed ID: 1581893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.
    Cohn SL; Salwen H; Quasney MW; Ikegaki N; Cowan JM; Herst CV; Kennett RH; Rosen ST; DiGiuseppe JA; Brodeur GM
    Oncogene; 1990 Dec; 5(12):1821-7. PubMed ID: 2284101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nerve growth factor-induced differentiation of human neuroblastoma and neuroepithelioma cell lines.
    Chen J; Chattopadhyay B; Venkatakrishnan G; Ross AH
    Cell Growth Differ; 1990 Feb; 1(2):79-85. PubMed ID: 1964795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas.
    Eggert A; Ikegaki N; Kwiatkowski J; Zhao H; Brodeur GM; Himelstein BP
    Clin Cancer Res; 2000 May; 6(5):1900-8. PubMed ID: 10815914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of N-myc in phenotypically distinct subclones of a human neuroblastoma cell line.
    Foley J; Cohn SL; Salwen HR; Chagnovich D; Cowan J; Mason KL; Parysek LM
    Cancer Res; 1991 Dec; 51(23 Pt 1):6338-45. PubMed ID: 1933896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation.
    Raschella G; Romeo A; Negroni A; Pucci S; Dominici C; Castello MA; Bevilacqua P; Felsani A; Calabretta B
    Cancer Res; 1994 Apr; 54(8):2251-5. PubMed ID: 8174135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro modulation and relationship between N-myc and HLA class I RNA steady-state levels in human neuroblastoma cells.
    Gross N; Beck D; Favre S
    Cancer Res; 1990 Dec; 50(23):7532-6. PubMed ID: 1701347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human neuroblastoma cells express alpha and beta platelet-derived growth factor receptors coupling with neurotrophic and chemotactic signaling.
    Matsui T; Sano K; Tsukamoto T; Ito M; Takaishi T; Nakata H; Nakamura H; Chihara K
    J Clin Invest; 1993 Sep; 92(3):1153-60. PubMed ID: 8376577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.